Eltoprazine (hydrochloride)
Modify Date: 2024-01-06 19:33:02
Eltoprazine (hydrochloride) structure
|
Common Name | Eltoprazine (hydrochloride) | ||
|---|---|---|---|---|
| CAS Number | 98206-09-8 | Molecular Weight | 256.72900 | |
| Density | 1.18g/cm3 | Boiling Point | 384.3ºC at 760 mmHg | |
| Molecular Formula | C12H17ClN2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 186.2ºC | |
Use of Eltoprazine (hydrochloride)Eltoprazine(DU28853) is a serenic or antiaggressive agent which as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.IC50 value:Target: 5-HT1A/1B agonist; 5-HT2C antagonistin vitro: The binding of [3H]eltoprazine to whole tissue sections was saturable and revealed an apparent dissociation constant (Kd) of 11 nM. Specific [3H]eltoprazine binding was completely displaced by 5-HT; conversely, unlabelled eltoprazine reduced [3H]5-HT binding to the levels of non-specific binding [1]. Eltoprazine evoked membrane changes that were similar to but much weaker than those induced by 5HT. Both the 5HT- and eltoprazine-evoked membrane hyperpolarizations were largely suppressed in the presence of spiperone [2].in vivo: eltoprazine is extremely effective in suppressing dyskinesia in experimental models, although this effect was accompanied by a partial worsening of the therapeutic effect of l-dopa. Interestingly, eltoprazine was found to (synergistically) potentiate the antidyskinetic effect of amantadine. The current data indicated that eltoprazine is highly effective in counteracting dyskinesia in preclinical models [3]. Rats were chronically treated with mianserin (10 mg/kg i.p.) or eltoprazine (1 mg/kg i.p.) and were tested in the elevated plus-maze test for anxiety. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones [4]. |
| Name | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine |
|---|---|
| Synonym | More Synonyms |
| Description | Eltoprazine(DU28853) is a serenic or antiaggressive agent which as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.IC50 value:Target: 5-HT1A/1B agonist; 5-HT2C antagonistin vitro: The binding of [3H]eltoprazine to whole tissue sections was saturable and revealed an apparent dissociation constant (Kd) of 11 nM. Specific [3H]eltoprazine binding was completely displaced by 5-HT; conversely, unlabelled eltoprazine reduced [3H]5-HT binding to the levels of non-specific binding [1]. Eltoprazine evoked membrane changes that were similar to but much weaker than those induced by 5HT. Both the 5HT- and eltoprazine-evoked membrane hyperpolarizations were largely suppressed in the presence of spiperone [2].in vivo: eltoprazine is extremely effective in suppressing dyskinesia in experimental models, although this effect was accompanied by a partial worsening of the therapeutic effect of l-dopa. Interestingly, eltoprazine was found to (synergistically) potentiate the antidyskinetic effect of amantadine. The current data indicated that eltoprazine is highly effective in counteracting dyskinesia in preclinical models [3]. Rats were chronically treated with mianserin (10 mg/kg i.p.) or eltoprazine (1 mg/kg i.p.) and were tested in the elevated plus-maze test for anxiety. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones [4]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.18g/cm3 |
|---|---|
| Boiling Point | 384.3ºC at 760 mmHg |
| Molecular Formula | C12H17ClN2O2 |
| Molecular Weight | 256.72900 |
| Flash Point | 186.2ºC |
| Exact Mass | 256.09800 |
| PSA | 33.73000 |
| LogP | 2.06320 |
| Index of Refraction | 1.562 |
| Eltoprazinum [Latin] |
| Eltoprazine |
| Eltoprazina |
| Eltoprazina [Spanish] |
| 1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine |
| Eltoprazine hydrochloride |
| Eltoprazine (hydrochloride) |